Baran Umut Vardar

Baran Umut Vardar

Auto-generated profile, based on publicly available information

Baran Umut Vardar

From the Department of Radiology, Division of Abdominal Imaging (B.V., T.P.) and Gillette Center for Women’s Cancers (A.B., A.M.), Massachusetts General Hospital, 55 Fruit St, White 270, Boston, MA 02114

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2022 in Ultrasonography
Verified
Journal Article
Open access
PDF file
BVBaran Umut Vardar
Baran Umut Vardar
CDCarolyn S. Dupuis
Carolyn S. Dupuis
AGAlan J. Goldstein
Alan J. Goldstein
ZVZeynep Vardar
Zeynep Vardar
YKYoung Kim
Young Kim
Ultrasonography is often the initial modality used to evaluate patients found to have abnormal liver function tests (LFTs) in the emergency department. While an assessment for biliary ductal dilatation and obstruction remains one of the main questions to answer, radiologists should also be aware of the ultrasonographic appearance of other conditions that can cause abnormal LFTs. This may be crucial for the management and disposition of patients in the emergency department. This article reviews the ultrasonographic features of diseases that may cause abnormal LFTs.

8 April 2022 in Ultrasonography
Verified
Journal Article
Open access
PDF file
ZVZeynep Vardar
Zeynep Vardar
CDCarolyn Suzanne Dupuis
Carolyn Suzanne Dupuis
AGAlan Joshua Goldstein
Alan Joshua Goldstein
ESEfaza Siddiqui
Efaza Siddiqui
BVBaran Umut Vardar
Baran Umut Vardar
YKYoung Kim
Young Kim
Pelvic pain and vaginal bleeding are common symptoms in postpartum women presenting to the emergency room (ER). Pelvic ultrasonography plays a crucial role in evaluating symptomatic postpartum patients by allowing a rapid diagnosis and treatment initiation. The main goal of imaging is to distinguish between causes of pelvic pain and vaginal bleeding that may be managed conservatively and those requiring emergent intervention. This pictural essay focuses on the ultrasonographic features of common postpartum conditions for which patients may present to the ER with vaginal bleeding and pelvic pain, including retained products of conception, endometritis, uterine arteriovenous malformation, uterine artery pseudoaneurysm, ovarian vein thrombosis, bladder flap hematoma, and uterine dehiscence/rupture.

5 October 2024 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
SRShravya Srinivas Rao
Shravya Srinivas Rao
SGSoumyadeep Ghosh
Soumyadeep Ghosh
BVBaran U. Vardar
Baran U. Vardar
APAnkur Pandey
Ankur Pandey
NBNikitha Uma Baskaran
Nikitha Uma Baskaran
AKAvinash R. Kambadakone
Avinash R. Kambadakone

1 August 2021 in Radiology Case Reports
Verified
Journal Article
Open access
BVBaran Vardar
Baran Vardar
BMBrian Midkiff
Brian Midkiff
Vaginal cuff dehiscence is a rare but potentially life-threatening post-hysterectomy complication. Here we report two cases of vaginal cuff dehiscence with distinct imaging features and describe the CT findings of vaginal cuff dehiscence. Both patients underwent repair surgery, and the diagnoses were confirmed. Radiologic features of vaginal cuff dehiscence are uncommonly described in the literature. Vaginal cuff mural discontinuity and omental fat tissue or bowel herniation into the vaginal canal are the most common appearances of vaginal cuff dehiscence. Pelvic hematoma, bowel obstruction, and pneumoperitoneum can accompany. These two cases highlight the CT appearances, potential presentations, and management of vaginal cuff dehiscence in the emergency setting.

3 April 2022 in Cureus
Verified
Journal Article
Open access
BVBaran U. Vardar
Baran U. Vardar
EMEce Meram
Ece Meram
KKKerim Karaoglu
Kerim Karaoglu
MLMuxuan Liang
Muxuan Liang
MYMenggang Yu
Menggang Yu
OOOrhan S. Ozkan
Orhan S. Ozkan
Background and objective: In recent years, combination therapies for hepatocellular carcinoma (HCC) have been increasingly used with superior treatment responses compared to monotherapies. However, the safety and efficacy of the transarterial chemoembolization (TACE) and transarterial radioembolization (TARE) combinations for HCC patients have not been investigated in the literature. In this study, our aim was to evaluate the safety and outcomes of TACE after TARE in HCC patients. Materials and methods: All TARE procedures performed on HCC patients at a single institution between January 2008 and November 2016 were retrospectively reviewed. Seventy-three patients who did not receive any additional transarterial therapy in the areas targeted by TARE were assigned to the “TARE group,” while 27 patients who received TACE after TARE to the same target area were assigned to the “Combo group.” Post-procedural liver toxicity, tumor response, overall survival (OS), and time to progression (TTP) were evaluated. Results: Fewer patients in the Combo group had worsening liver function than the TARE group based on the change in bilirubin levels (19% vs. 40%; p=0.029) and Child-Pugh score increase (28% vs. 51%; p=0.056). The median OS time of all patients was 11.04 months. The Combo group had a significantly longer median OS of 36.8 months (vs. 10.6, p=0.003) and median TTP of 14.4 months (vs. 5.5, p=0.018). After accounting for selection bias, OS and TTP were still in favor of the Combo group, with hazard ratios of 0.651 (p<0.05) and 0.63 (p<0.05), respectively. Conclusion: The addition of TACE to TARE is a safe and effective treatment in unresectable HCC patients and can be considered in select patients with a lack of complete response or disease progression.

1 November 2024 in Radiology: Imaging Cancer
Verified
Journal Article
Closed access
BVBaran Vardar
Baran Vardar
ABAlexandra Bercow
Alexandra Bercow
AMAlexander Melamed
Alexander Melamed
TPTheodore Pierce
Theodore Pierce